{
  "abstract": "IntroductionMiltefosine is the only approved oral antileishmanial agent, but its use in women of childbearing potential (WOCBP) is restricted due to preclinical teratogenicity. Current labeling recommends contraception during treatment and for at least five months thereafter, based solely on its long terminal elimination half-life. This study re-evaluated the required contraceptive duration using an exposure margin-based approach.\n\nMethodsVirtual populations were generated from anthropometric data of 382 Indian, 4,462 Eastern African, and 4,019 Brazilian WOCBP with leishmaniasis. Published population pharmacokinetic models were used to simulate miltefosine exposure following 14-42 days regimens for visceral leishmaniasis (VL), post-kala-azar dermal leishmaniasis (PKDL), and cutaneous leishmaniasis (CL). A developmental safety exposure threshold was derived from the rat no-observed-adverse-effect level (0.6 mg/kg/day for 10 days) and adjusted using a 10-fold safety margin. Contraceptive durations resulting in median residual post-contraception exposure (AUCEOC-{infty}) below this threshold were considered supportive of contraceptive discontinuation.\n\nResultsThe developmental safety exposure threshold was estimated at 2.5 mg{middle dot}day/L. Despite pharmacokinetic differences across geographical regions and disease manifestations, required minimum contraceptive durations were consistent: three months from treatment initiation for the 14-day regimen, four months for 21- and 28-day regimens, and five months for the 42-day regimen. For the 14-day regimen, a single dose of a long-acting injectable contraceptive administered at treatment initiation would provide sufficient coverage.\n\nConclusionAn exposure margin-based approach supports shorter contraceptive durations than current recommendations. For the 14-day VL regimen, three months of contraception may provide a practical alternative to current labeling.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Pharmacy, Uppsala University, Uppsala, Sweden"
  ],
  "article_type": "PUBLISHAHEADOFPRINT",
  "arxiv": null,
  "author_total": 3,
  "authors": [
    {
      "name": "W.-Y. Chu"
    },
    {
      "name": "F. Alves"
    },
    {
      "affs": [
        0
      ],
      "name": "T. P. C. Dorlo"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/9bpf792v0ehdr.bib",
  "cited_by": 0,
  "doi": "10.64898/2026.08.31.26360682",
  "fulltext_url": "https://www.medrxiv.org/content/10.64898/2026.08.31.26360682v1.full",
  "id": "9bpf792v0ehdr",
  "issns": [],
  "landing_url": "https://www.medrxiv.org/content/10.64898/2026.08.31.26360682v1",
  "language": null,
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "medrxiv",
      "infectious diseases"
    ],
    [
      "openalex",
      "2739|Research on Leishmaniasis Studies"
    ]
  ],
  "openalex": "W7206157412",
  "pdf_url": "https://www.medrxiv.org/content/10.64898/2026.08.31.26360682v1.full.pdf",
  "pmcid": null,
  "pmid": null,
  "published": "2026-08-31",
  "publisher": null,
  "ris": "https://research.draconitic.com/paper/9bpf792v0ehdr.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:17:31Z",
      "native_id": "10.64898/2026.08.31.26360682",
      "source": "medrxiv",
      "url": "https://www.medrxiv.org/content/10.64898/2026.08.31.26360682v1"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "medrxiv:infectious diseases",
      "subfield": "infectious-disease"
    }
  ],
  "title": "Female contraceptive cover duration for miltefosine-containing regimens for the treatment of women with leishmaniasis",
  "title_text": "Female contraceptive cover duration for miltefosine-containing regimens for the treatment of women with leishmaniasis",
  "type": "preprint",
  "updated_at": "2026-10-30T12:17:31Z",
  "url": "https://research.draconitic.com/paper/9bpf792v0ehdr",
  "venue": "medRxiv",
  "versions": []
}